Supplementary data for Pisani et al: COVID-19 may expand the market for substandard and fake medicines
<|begin_of_text|><|start_header_id|>system<|end_header_id|> You are a research archivist expert in dataset metadata. Answer the question truthfully.  <|eot_id|><|start_header_id|>user<|end_header_id|> Here is the Description of a dataset. Description:'These data are compiled from UN Comtrade (global exports of raw materials for antibiotic production); United States Food and Drug Administration (shortages database); UK Pharmaceutical Services Negotiating Committee (price concessions); UK Department of Health and Social Care (ban on medicine exports)  and  Central Drugs Standard Control Organisation, India (post-market surveillance)' . Please return only a json list of at most 3 Keywords corresponding to the Description:.<|eot_id|><|start_header_id|>assistant<|end_header_id|> {"Answer" : ["medicine, pharmaceutical, trade, export, shortages, drug regulation"]} <|eot_id|>
 Here is the Description of a dataset. Description:'These data are compiled from UN Comtrade (global exports of raw materials for antibiotic production); United States Food and Drug Administration (shortages database); UK Pharmaceutical Services Negotiating Committee (price concessions); UK Department of Health and Social Care (ban on medicine exports)  and  Central Drugs Standard Control Organisation, India (post-market surveillance)' . Please return only a json list of at most 3 Keywords corresponding to the Description:.
These data are compiled from UN Comtrade (global exports of raw materials for antibiotic production); United States Food and Drug Administration (shortages database); UK Pharmaceutical Services Negotiating Committee (price concessions); UK Department of Health and Social Care (ban on medicine exports)  and  Central Drugs Standard Control Organisation, India (post-market surveillance)
medicine, pharmaceutical, trade, export, shortages, drug regulation